Surgery Partners (NASDAQ:SGRY) Shares Up 4.5%

Surgery Partners, Inc. (NASDAQ:SGRY)’s stock price traded up 4.5% during trading on Friday . The company traded as high as $24.91 and last traded at $24.75. 295,910 shares were traded during mid-day trading, a decline of 67% from the average session volume of 894,680 shares. The stock had previously closed at $23.69.

Analysts Set New Price Targets

A number of analysts recently commented on the company. Cantor Fitzgerald reiterated an “overweight” rating and set a $43.00 price objective on shares of Surgery Partners in a research report on Wednesday, April 10th. Citigroup reduced their target price on shares of Surgery Partners from $42.00 to $38.00 and set a “buy” rating for the company in a report on Wednesday, May 8th. Benchmark restated a “buy” rating and issued a $50.00 price target on shares of Surgery Partners in a research report on Wednesday, May 1st. Barclays started coverage on shares of Surgery Partners in a report on Wednesday, March 6th. They issued an “equal weight” rating and a $35.00 target price for the company. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $49.00 price objective on shares of Surgery Partners in a research note on Thursday, February 29th. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Surgery Partners currently has an average rating of “Moderate Buy” and an average price target of $42.86.

Surgery Partners Stock Performance

The firm’s 50 day simple moving average is $25.52 and its 200 day simple moving average is $29.18. The firm has a market cap of $3.11 billion, a PE ratio of 27.55, a PEG ratio of 1.80 and a beta of 2.73. The company has a current ratio of 1.71, a quick ratio of 1.56 and a debt-to-equity ratio of 0.92.

Surgery Partners (NASDAQ:SGRY) last posted its earnings results on Tuesday, May 7th. The company reported $0.06 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.02. Surgery Partners had a return on equity of 3.65% and a net margin of 0.02%. The company had revenue of $717.40 million for the quarter, compared to the consensus estimate of $707.66 million. On average, research analysts forecast that Surgery Partners, Inc. will post 0.88 EPS for the current fiscal year.

Insider Activity at Surgery Partners

In other Surgery Partners news, insider Danielle Burkhalter sold 6,000 shares of Surgery Partners stock in a transaction on Wednesday, June 12th. The shares were sold at an average price of $26.39, for a total value of $158,340.00. Following the completion of the transaction, the insider now directly owns 30,354 shares of the company’s stock, valued at approximately $801,042.06. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 2.30% of the stock is owned by insiders.

Hedge Funds Weigh In On Surgery Partners

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Wellington Management Group LLP lifted its position in Surgery Partners by 3.7% in the fourth quarter. Wellington Management Group LLP now owns 8,318,176 shares of the company’s stock worth $266,098,000 after buying an additional 295,476 shares during the last quarter. Vanguard Group Inc. lifted its holdings in shares of Surgery Partners by 0.8% in the 1st quarter. Vanguard Group Inc. now owns 7,479,009 shares of the company’s stock worth $223,099,000 after acquiring an additional 61,400 shares during the last quarter. Clearbridge Investments LLC grew its holdings in Surgery Partners by 4.7% during the 4th quarter. Clearbridge Investments LLC now owns 5,525,671 shares of the company’s stock valued at $176,766,000 after purchasing an additional 247,762 shares during the last quarter. Invesco Ltd. grew its holdings in Surgery Partners by 9.3% during the 3rd quarter. Invesco Ltd. now owns 3,604,357 shares of the company’s stock valued at $105,427,000 after purchasing an additional 305,216 shares during the last quarter. Finally, Janus Henderson Group PLC raised its position in Surgery Partners by 7,987.1% in the 1st quarter. Janus Henderson Group PLC now owns 2,504,248 shares of the company’s stock worth $74,701,000 after purchasing an additional 2,473,282 shares during the period.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.